Dr. Elbuluk’s clinical and research interests include general medical and cosmetic dermatology,
ethnic skin conditions, and pigmentary disorders including vitiligo, melasma, and postinflammatory pigmentation. She performs a variety of procedures including chemical peels, microneedling, lasers, and botox and has expertise in safely performing these procedures in all skin types.
Dr. Elbuluk received her bachelor’s degree in Psychology from Princeton University where she also minored in Gender Studies and African American Studies. She completed her medical degree at the University of Michigan where she graduated with a Distinction in Research. While there, she received a National Institute of Health award that allowed her to also obtain a Master of Science in Clinical Research from the University of Michigan School of Public Health. She completed her dermatology residency at Johns Hopkins Hospital. Afterwards, she was a fellow and clinical instructor in the Dermatology Department at The University of Pennsylvania. She then spent four years as an Assistant Professor at New York University’s School of Medicine, where she was the founder and director of the pigmentary disorder clinic and served as the Diversity Ambassador for the Department.
Dr. Elbuluk feels strongly about providing her patients with the highest quality of individualized and compassionate care. She also is passionate about teaching and advancing the field of dermatology through research on pigmentary disorders and ethnic skin conditions. She has received several grants to support her research, which has been published in numerous academic journals. She has lectured both national and internationally on her areas of expertise. She also serves as a media expert for the American Academy of Dermatology and has been interviewed by numerous media outlets including the Washington Post, Health, Women’s Health, Essence, Prevention, Allure, Reader’s Digest, the Huffington Post, SELF, and NBC.com.
Dr. Elbuluk is a Diplomate of the American Academy of Dermatology and holds professional memberships with the American Academy of Dermatology, the Women’s Dermatologic Society, the American Society for Dermatologic Surgery, and the Skin of Color Society.
Frontal fibrosing alopecia: cutaneous associations in women with skin of color Cutis. 2018 Nov; 102(5):335-338. . View in PubMed
Deficiency of sun protection advertising exists in consumer magazines across demographic groups and varies by target demographic J Am Acad Dermatol. 2018 Oct 10. . View in PubMed
International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation Br J Dermatol. 2018 Jul 21. . View in PubMed
Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo J Drugs Dermatol. 2018 Jun 01; 17(6):688-691. . View in PubMed
Disparity in Cutaneous Pigmentary Response to LED vs Halogen Incandescent Visible Light: Results from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose J Drugs Dermatol. 2017 Nov 01; 16(11):1105-1110. . View in PubMed
Melasma: an Up-to-Date Comprehensive Review Dermatol Ther (Heidelb). 2017 Sep; 7(3):305-318. . View in PubMed
The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone Exp Dermatol. 2017 Jul; 26(7):637-644. . View in PubMed
Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients Dermatol Clin. 2017 Apr; 35(2):117-128. . View in PubMed
A Difference in Cutaneous Pigmentary Response to LED Versus Halogen Incandescent Visible Light: A Case Report from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose J Drugs Dermatol. 2017 Apr 01; 16(4):388-392. . View in PubMed
Microneedling: A Comprehensive Review Dermatol Surg. 2017 Mar; 43(3):321-339. . View in PubMed
The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone Exp Dermatol. 2017 07; 26(7):637-644. . View in PubMed
Daily indoor light exposure: A spectral analysis of ambient light sources and its relevance to occupational dermatology J Am Acad Dermatol. 2017 04; 76(4):763-765. . View in PubMed
Advances in Vitiligo: An Update on Medical and Surgical Treatments J Clin Aesthet Dermatol. 2017 Jan; 10(1):15-28. . View in PubMed
Lichen planus pigmentosus Dermatol Online J. 2016 Dec 15; 22(12). . View in PubMed
Lichen planus pigmentosus and lichen planopilaris Dermatol Online J. 2016 Dec 15; 22(12). . View in PubMed
Common conditions in skin of color Semin Cutan Med Surg. 2016 Dec; 35(4):184-190. . View in PubMed
Infrared irradiation differentially alters collagen metabolism in lightly and darkly pigmented human skin in vivo J Dermatol Sci. 2016 Jun; 82(3):212-4. . View in PubMed
Microneedling in skin of color: A review of uses and efficacy J Am Acad Dermatol. 2016 Feb; 74(2):348-55. . View in PubMed
Cutaneous Rosai-Dorfman Disease in a Patient with Human Immunodeficiency Virus Dermatol Online J. 2016 Jan 15; 22(1). . View in PubMed
Recent advances in understanding vitiligo F1000Res. 2016; 5. . View in PubMed
Alternative Systemic Treatments for Vitiligo: A Review Am J Clin Dermatol. 2015 Dec; 16(6):463-74. . View in PubMed
Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses Am J Pathol. 2011 Apr; 178(4):1434-41. . View in PubMed
Cutis. 2011 Feb; 87(2):65, 76-7. . View in PubMed
Erythema nodosum leprosum, Sweet's syndrome, and human immunodeficiency virus may be related through an overlap in immunopathogenesis Int J Dermatol. 2010 Nov; 49(11):1344-5. . View in PubMed
Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne J Am Acad Dermatol. 2009 Aug; 61(2):252-8. . View in PubMed